|
Formulary
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Requip CR.(Approvable designations)
September 01, 2007
Trexima.(Approvable designations)
September 01, 2007
Pristig.(Approvable designations)
September 01, 2007
Satraplatin.(NDA withdrawn)
September 01, 2007
Kuvan.(Priority review)
September 01, 2007
Hycamtin.(Priority review)
September 01, 2007
Corlux.(Orphan drug designations)
September 01, 2007
VitiGam.(Orphan drug designations)
September 01, 2007
Exelon patch: rivastigmine transdermal system.(New molecular entity)
September 01, 2007
First-time generic, approvals.(FDA Drug Approvals)(Brief article)
September 01, 2007
Tamiflu.(FDA actions in brief)
September 01, 2007
Stalevo.(FDA actions in brief)
September 01, 2007
Evamist.(FDA actions in brief)
September 01, 2007
Sanctura XR.(FDA actions in brief)
September 01, 2007
Thrombin-JMI Epistaxis Kit.(FDA actions in brief)
September 01, 2007
Advate.(FDA actions in brief)(Brief article)
September 01, 2007
IV bisphosphonates may cause inflammatory conditions, osteomyelitis of...
September 01, 2007
Zelnorm.(Med Safety action in brief)
September 01, 2007
At a joint meeting of FDA's Dermatologic and Ophthalmic Drugs and Drug...
September 01, 2007
Management of Parkinson disease: current treatments, recent advances, ...
September 01, 2007
Telavancin: a novel lipoglycopeptide antibiotic with dual mechanisms o...
September 01, 2007
Use of broad-spectrum antibiotics during infancy associated with incre...
September 01, 2007
Patients treated with proton-pump inhibitors at increased risk for com...
September 01, 2007
Topiramate: an effective add-on treatment in obese, drug-naive patient...
September 01, 2007
Kiacta.(Approvable designations)
September 01, 2007
Evista.(Recommendations for approval)
September 01, 2007
Tysabri.(Recommendations for approval)
September 01, 2007
Bifeprunox.(Nonapprovable designations)
September 01, 2007
Selzentry: maraviroc.(New molecular entity)
September 01, 2007
Privigen: immune globulin intravenous (human), 10% liquid.(New formula...
September 01, 2007
Advair Diskus 500/50.(Nonapprovable designations)
September 01, 2007
Bupropion.(Nonapprovable designations)
September 01, 2007
LX211.(Fast-track designations)
September 01, 2007
TZP-101.(Fast-track designations)
September 01, 2007
Generx.(Fast-track designations)
September 01, 2007
Alzhemed.(Fast-track designations)
September 01, 2007
Rilonacept.(Priority review)
September 01, 2007
Abilify.(Priority review)
September 01, 2007
Statin pill-splitting has no significant effect on adherence or lipid ...
September 01, 2007
Researchers say benefits of antidepressants among pediatric patients o...
September 01, 2007
Correction.(News Capsules)(Correction notice)
September 01, 2007
Faropenem.(Selected literature)(Brief article)
September 01, 2007
Gemifloxacin.(Selected literature)(Brief article)
September 01, 2007
Safety labeling update.(Medication Safety and Reliability: A COLLECTIO...
September 01, 2007
Current use of HRT linked to increased risk of ovarian cancer and deat...
September 01, 2007
Initial sitagliptin plus metformin demonstrated to be effective in pat...
September 01, 2007
PDUFA legislative proposals call for increased fees to help improve dr...
September 01, 2007
Sublingual tablet-based allergy immunotherapy.(Selected literature)(Br...
September 01, 2007
Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.(Selected literatur...
September 01, 2007
Selected websites.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE-S...
September 01, 2007
Allergic rhinitis and sinusitis/rhinosinusitis.(Drug Watch: A HEADS-UP...
September 01, 2007
Anticoagulation in non-ST-Segment elevation acute coronary syndromes (...
September 01, 2007
|